The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure. The FDA has approved Hibsago (bepirovirsen), GSK’s antisense oligonucleotide, for adults with chronic hepatitis B who are already taking…
NASHVILLE — In this Healio video, Arun B. Jesudian, MD, discusses hepatitis B developments including new therapies for highly selective patients, updated treatment guidelines and different vaccination recommendations from the ACG Annual Meeting.“The hepatitis B space is changing and, particularly,…
Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share. About 90% of dispensed biologics in British Columbia, the first Canadian province to adopt mandatory switching, are biosimilars, O’Rourke said.2 Manitoba…
ST. LOUIS, Mo. (First Alert 4) - Missouri Attorney General Catherine Hanaway announced Monday she has sent a cease-and-desist letter to the drug manufacturer Eli Lilly. The attorney general’s office says Eli Lilly has been imposing unlawful conditions on hospitals participating in…
The study set out to characterize how NK cell phenotypes, receptor expression and cytokine profiles change during this combination regimen and how those changes relate to clinical outcomes. HBsAg loss remains a major challenge in chronic hepatitis B, and identifying…
ZILBRYSQ is the first and only macrocyclic peptide C5 inhibitor approved as a self-administered once-daily, subcutaneous autoinjector for adults living with generalized myasthenia gravis (gMG) in the U.S.¹ ZILBRYSQ now offers two self-administration options for adults living with gMG who are anti-acetylcholine…
Five Massachusetts hospitals sued drugmaker Eli Lilly on Tuesday for allegedly violating a federal law that requires pharmaceutical companies to sell outpatient drugs at discounted prices to health care organizations that care for uninsured and poor patients. The suit alleges…
17 Dec, 2025, 08:00 CST Historical Inheritance: From Folk Remedies to a Publicly Listed Company Technological Innovation: A Key Breakthrough for the Modernization of Hakka Medicine On the raw materials side, Jiaying Pharmaceutical invested in a borneol production base to achieve direct supply…
Missouri Attorney General Catherine Hanaway has issued a cease-and-desist letter to Eli Lilly and Company, ordering the pharmaceutical manufacturer to discontinue requirements that her office alleges unlawfully restrict Missouri hospitals’ access to discounted prescription medications through the federal 340B Drug Pricing…
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size. ACT Brief: Applied Clinical Trials at 2026 SCRS…
Regulators, approvals and the rules that shape biotech: FDA decisions and leadership, drug-pricing and trade policy, and regulators abroad.
An article joins this feed when it matches these terms. Each one is also a search of its own.